Data of an epidemiologic study of @entity43 in Israel are presented. During the 5-year period of this survey, 1001 new cases of primary @entity43 were diagnosed. The findings are compared with those of two previous surveys covering the periods 1960-1965 (746 cases) and 1966-1971 (911 cases). The incidence during the 17-year period ranged between 15 and 19/100,000 @entity1 over the age of 15. The disease was three to five times more prevalent in @entity1 of European/American origin than in those of Asian/African descent. Seventy-five percent of the @entity1 were between the ages of 45 and 74. The majority (50-71%) were already in stage III or stage IV at diagnosis. Factors affecting the prognosis are the age of the @entity1 and clinical stage of the @entity5 when first diagnosed, histology of the @entity5 , and type of treatment. Although the time interval between onset of the disease and its detection has remained protracted, the 5-year survival rate was improved from 15% during the period 1960-1965 to 31% between the years 1972-1976. This favorable trend is to be ascribed to new treatment modalities.

Trends in the incidence of XXXX in a heterogenic population (1960-1976).

@entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian cancer', 'cancer of the ovary'] @entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'malignancy']
@entity43 :: (MESH:D010051,Disease) :: ['ovarian cancer']
